LumpTamoxifenPalbociclibER-LCISAngiogenesisLymphNodeStatusMorpheaPhyllodesTumorMRIHerceptinChemotherapyFlowCytometryEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCystFamilyHistoryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCMFChemotherapyPathologicResponseBrachytherapyRADDown-StagingAromataseInhibitorsAntiemeticAdjuvantTherapyBevacizumabGeneticCounselingFibroadenomaAyurvedaMastodyniaImmunotherapyCachexiaLapatinibNeoadjuvantTherapyPalpationStagingPagetDiseaseDoxorubicinBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Physicalactivity mayreduce therisk of breastcancersGenomicTestingAxillarySamplingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.In-situCarcinomaKi-67RateCalcificationsOvarianSuppressionWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PrecisionMedicineGuaranteedRenewableInsuranceCo-survivormTORInhibitorsApoptosisTriple +/-BreastCancerDocetaxelGeneMutationOligometastasesER+Women ages40+ shouldhave a clinicalbreast examat least yearlyPI3KinaseInhibitorsBI-RADSMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltProgestinChemopreventionAdvocacyBreastCancerLymphoscintigraphyBOCAPARPInhibitorsRadiotherapyACChemotherapyMastectomyECOGScoreCheckpointInhibitorHormoneReceptorStatusBilateralProphylacticMastectomyCAMLumpectomyMultimodalityTherapyKappaEpsilonSelf-examinationCapecitabineTyrosine-KinaseInhibitorCytostaticRelapseBreastTomosynthesisEstrogenAnastrozoleSERMGeneticPredispositionEstradiolDimplingMultifocalTumorsIntraductalPapillomaAbsoluteRisk1 in 8womenHER-2AntibodyTherapyCyclophosphamideEGFR5-FluorouracilPaclitaxelBRCAGeneTumorGradeHormoneReplacementTherapyDoseDenseTherapyCytotoxicBiopsyMegestrolAcetateRaloxifeneMetastasisGermlineMutationAdenocarcinomaFISHAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDefinitiveSurgeryMethotrexateAlopeciaCDK4/6InhibitorsGailModelLumpTamoxifenPalbociclibER-LCISAngiogenesisLymphNodeStatusMorpheaPhyllodesTumorMRIHerceptinChemotherapyFlowCytometryEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCystFamilyHistoryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCMFChemotherapyPathologicResponseBrachytherapyRADDown-StagingAromataseInhibitorsAntiemeticAdjuvantTherapyBevacizumabGeneticCounselingFibroadenomaAyurvedaMastodyniaImmunotherapyCachexiaLapatinibNeoadjuvantTherapyPalpationStagingPagetDiseaseDoxorubicinBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Physicalactivity mayreduce therisk of breastcancersGenomicTestingAxillarySamplingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.In-situCarcinomaKi-67RateCalcificationsOvarianSuppressionWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PrecisionMedicineGuaranteedRenewableInsuranceCo-survivormTORInhibitorsApoptosisTriple +/-BreastCancerDocetaxelGeneMutationOligometastasesER+Women ages40+ shouldhave a clinicalbreast examat least yearlyPI3KinaseInhibitorsBI-RADSMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltProgestinChemopreventionAdvocacyBreastCancerLymphoscintigraphyBOCAPARPInhibitorsRadiotherapyACChemotherapyMastectomyECOGScoreCheckpointInhibitorHormoneReceptorStatusBilateralProphylacticMastectomyCAMLumpectomyMultimodalityTherapyKappaEpsilonSelf-examinationCapecitabineTyrosine-KinaseInhibitorCytostaticRelapseBreastTomosynthesisEstrogenAnastrozoleSERMGeneticPredispositionEstradiolDimplingMultifocalTumorsIntraductalPapillomaAbsoluteRisk1 in 8womenHER-2AntibodyTherapyCyclophosphamideEGFR5-FluorouracilPaclitaxelBRCAGeneTumorGradeHormoneReplacementTherapyDoseDenseTherapyCytotoxicBiopsyMegestrolAcetateRaloxifeneMetastasisGermlineMutationAdenocarcinomaFISHAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenDefinitiveSurgeryMethotrexateAlopeciaCDK4/6InhibitorsGailModel

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Lump
  2. Tamoxifen
  3. Palbociclib
  4. ER-
  5. LCIS
  6. Angiogenesis
  7. Lymph Node Status
  8. Morphea
  9. Phyllodes Tumor
  10. MRI
  11. Herceptin
  12. Chemotherapy
  13. Flow Cytometry
  14. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  15. Cyst
  16. Family History
  17. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  18. CMF Chemotherapy
  19. Pathologic Response
  20. Brachytherapy
  21. RAD
  22. Down-Staging
  23. Aromatase Inhibitors
  24. Antiemetic
  25. Adjuvant Therapy
  26. Bevacizumab
  27. Genetic Counseling
  28. Fibroadenoma
  29. Ayurveda
  30. Mastodynia
  31. Immunotherapy
  32. Cachexia
  33. Lapatinib
  34. Neoadjuvant Therapy
  35. Palpation
  36. Staging
  37. Paget Disease
  38. Doxorubicin
  39. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  40. Physical activity may reduce the risk of breast cancers
  41. Genomic Testing
  42. Axillary Sampling
  43. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  44. In-situ Carcinoma
  45. Ki-67 Rate
  46. Calcifications
  47. Ovarian Suppression
  48. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  49. Precision Medicine
  50. Guaranteed Renewable Insurance
  51. Co-survivor
  52. mTOR Inhibitors
  53. Apoptosis
  54. Triple +/- Breast Cancer
  55. Docetaxel
  56. Gene Mutation
  57. Oligometastases
  58. ER+
  59. Women ages 40+ should have a clinical breast exam at least yearly
  60. PI3 Kinase Inhibitors
  61. BI-RADS
  62. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  63. Progestin
  64. Chemoprevention
  65. Advocacy
  66. Breast Cancer
  67. Lymphoscintigraphy
  68. BOCA
  69. PARP Inhibitors
  70. Radiotherapy
  71. AC Chemotherapy
  72. Mastectomy
  73. ECOG Score
  74. Checkpoint Inhibitor
  75. Hormone Receptor Status
  76. Bilateral Prophylactic Mastectomy
  77. CAM
  78. Lumpectomy
  79. Multimodality Therapy
  80. Kappa Epsilon
  81. Self-examination
  82. Capecitabine
  83. Tyrosine-Kinase Inhibitor
  84. Cytostatic
  85. Relapse
  86. Breast Tomosynthesis
  87. Estrogen
  88. Anastrozole
  89. SERM
  90. Genetic Predisposition
  91. Estradiol
  92. Dimpling
  93. Multifocal Tumors
  94. Intraductal Papilloma
  95. Absolute Risk
  96. 1 in 8 women
  97. HER-2
  98. Antibody Therapy
  99. Cyclophosphamide
  100. EGFR
  101. 5-Fluorouracil
  102. Paclitaxel
  103. BRCA Gene
  104. Tumor Grade
  105. Hormone Replacement Therapy
  106. Dose Dense Therapy
  107. Cytotoxic
  108. Biopsy
  109. Megestrol Acetate
  110. Raloxifene
  111. Metastasis
  112. Germline Mutation
  113. Adenocarcinoma
  114. FISH
  115. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  116. Definitive Surgery
  117. Methotrexate
  118. Alopecia
  119. CDK4/6 Inhibitors
  120. Gail Model